GlassScriptPhysician profile
Amanda C Phillips
NPI 1932308855
$376.40
in general payments reported to CMS, 2019-2025
15 companies · $65.90 in 2025
The $65.90 reported for 2025 was less than what a typical Women'S Health (Nurse Practitioner) provider received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $29.86 · 2022: $46.40 · 2023: $95.24 · 2024: $139 · 2025: $65.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $300.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $49.50 | 2023-2024 | Accrufer |
| Ascendis Pharma Endocrinology INC | $47.98 | 2025 | Yorvipath |
| Medicomp INC | $46.40 | 2022 | |
| Sanofi Pasteur INC. | $30.06 | 2023-2024 | |
| Novo Nordisk INC | $29.86 | 2021 | |
| Gilead Sciences, INC. | $23.82 | 2024 | |
| Ironshore Pharmaceuticals INC. | $18.64 | 2023 | Jornay Pm |
| Exact Sciences Corporation | $18.07 | 2024 | Cologuard Collection Kit |
| Sanofi-Aventis U.S. LLC | $17.92 | 2025 | |
| Merck Sharp & Dohme LLC | $16.24 | 2023 | Vaxneuvance, Vaxelis, Gardasil 9 |
| Pfizer INC. | $16.19 | 2023 | |
| Cranial Technologies, INC | $15.89 | 2024 | Doc Band |
| Astellas Pharma US INC | $15.71 | 2024 | Veozah |
| Vbi Vaccine (Delaware) INC. | $15.30 | 2023 | Prehevbrio |
| Lilly USA, LLC | $14.82 | 2024 | Mounjaro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Phillips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.